Y. Miyake, H. Ishida, M. Fukunaga, T. Kato, Y. Watanabe, H. Takemoto, H. Furukawa, Osaka gastrointestinal cancer chemotherapy study group (OGSG). (2008). A feasibility/phase II study of UFT/LV and irinotecan (TEGAFIRI) in advanced or metastatic colorectal cancer (CRC) (OGSG 0304) , 44th annual meeting of American society of clinical oncology (ASCO).